We are live on ! Find out more
PRTA icon

Prothena Corp

118 hedge funds and large institutions have $832M invested in Prothena Corp in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more capital invested

Capital invested by funds: $429M → $832M (+$402M)

83% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 23

71% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 17

10% more funds holding

Funds holding: 107118 (+11)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

6% less call options, than puts

Call options by funds: $8.75M | Put options by funds: $9.26M

Holders
118
Holders Change
+11
Holders Change %
+10.28%
% of All Funds
3.41%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
29
Increased
42
Reduced
23
Closed
17
Calls
$8.75M
Puts
$9.26M
Net Calls
-$515K
Net Calls Change
-$2.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$149M +$36.4M +1,128,289 +41%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$86.4M +$25.7M +798,590 +55%
O
3
OrbiMed
New York
$72.4M +$22.1M +687,000 +57%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$62.3M +$6.67M +206,940 +15%
RCM
5
RA Capital Management
Massachusetts
$59.6M -$2.78M -86,249 -5%
Capital World Investors
6
Capital World Investors
California
$31.7M +$26.6M +826,620 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$31.3M -$4.84M -150,000 -16%
Jennison Associates
8
Jennison Associates
New York
$29.5M -$2.03M -63,121 -8%
Millennium Management
9
Millennium Management
New York
$28.4M +$17.8M +552,318 +293%
BFA
10
BlackRock Fund Advisors
California
$25.5M +$634K +19,656 +3%
RG
11
Redmile Group
California
$21.4M +$17.7M +550,511 +6,050%
PHS
12
PFM Health Sciences
California
$20.8M +$17.5M +541,983 New
PAI
13
Palo Alto Investors
California
$20.4M -$145K -4,500 -0.8%
Westfield Capital Management
14
Westfield Capital Management
Massachusetts
$19.6M -$13.8M -426,850 -45%
CAM
15
Cormorant Asset Management
Massachusetts
$13.4M +$11.3M +350,000 New
PA
16
Perceptive Advisors
New York
$13.4M +$11.3M +350,000 New
GC
17
Guggenheim Capital
Illinois
$10.2M +$446K +13,830 +6%
Norges Bank
18
Norges Bank
Norway
$9.74M -$192K -5,969 -2%
Vanguard Group
19
Vanguard Group
Pennsylvania
$9.3M +$2.4M +74,387 +44%
BBA
20
Baker Bros. Advisors
New York
$8.82M -$3.44M -106,776 -32%
State Street
21
State Street
Massachusetts
$8.37M +$755K +23,421 +12%
Morgan Stanley
22
Morgan Stanley
New York
$7.99M +$6.49M +201,182 +2,713%
Northern Trust
23
Northern Trust
Illinois
$7.34M -$196K -6,068 -3%
BIT
24
BlackRock Institutional Trust
California
$6.65M +$242K +7,504 +5%
CCM
25
Cupps Capital Management
Illinois
$6.29M +$5.29M +164,199 New

PRTA Hedge Fund Activity: Q1 2014 in Review

118 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q1 2014, worth a combined $832M — up 94% from $429M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PRTA positions and 17 closed out — a net gain of 12 holders — while 42 added to existing stakes and 23 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $14M sold.

  • 118 institutional investors held Prothena Corp (PRTA) as of Q1 2014, up from 107 in Q4 2013.
  • Funds reported $832M of Prothena Corp stock for Q1 2014, up 94% quarter-over-quarter.
  • 29 funds opened new Prothena Corp positions in Q1 2014 and 17 closed out, a net change of +12 holders.
  • The largest Prothena Corp buyer in Q1 2014 was Fidelity Investments, an estimated $36.4M added.
  • The largest Prothena Corp seller in Q1 2014 was Deerfield Management, an estimated $14M sold.

Based on aggregated 13F filings for Q1 2014.